Sign in

CIK 0001072379

  • Non-accelerated filer
  • Smaller reporting company

NORTHWEST BIOTHERAPEUTICS INC

Sign in to watch
Ticker
NWBO
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943306718
Phone
+1 240-497-9024
Business address
4800 MONTGOMERY LANE, SUITE 800, BETHESDA, MD, 20814
  1. 4 Open-market buy Director bought 10,000 shares at $0.00 ($10)
  2. 4 Open-market buy Director bought 79,317 shares at an average $5.16 ($409,294)
  3. 4 Open-market buy Director bought 135,417 shares at $5.60 ($758,335)
  4. 4/A Open-market sale 10% owner sold 548,273 shares at an average $4.42 ($2,423,981)
  5. 4/A Open-market sale 10% owner sold 678,858 shares at an average $3.17 ($2,153,674)
  6. 4 Open-market sale 10% owner sold 548,273 shares at an average $4.42 ($2,423,981)
  7. 4 Open-market sale 10% owner sold 678,858 shares at an average $3.17 ($2,153,674)
  8. 4 Open-market buy 10% owner bought 6,891,550 shares at $4.00 ($11,608,288)
  9. 4 Open-market sale 10% owner sold 860,000 shares at $1.08 ($928,800)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Chairperson, CEO bought 6,468,153 shares
  12. 4 Gift Chairperson, CEO gave 950,000 shares (gift)
  13. 4 Gift Chief Scientific Officer gave 210,935 shares (gift)
  14. 4 Derivatives Options or other derivatives
  15. 4/A Gift Director gave 950,000 shares (gift)
  16. 4 Gift Chief Executive Officer gave 60,000 shares (gift)
  17. 4 Grant or award Chief Executive Officer acquired 243,432 shares (grant or award)
  18. 4 Gift Director gave 950,000 shares (gift)
  19. 4 Open-market sale Director sold 750,000 shares at an average $0.93 ($697,489)
  20. 4 Gift Chief Executive Officer gave 260,007 shares (gift)

Page 3 of 6 · 107 filings